PITTSBURGH, PA
— Ortho-tag, Inc., a high-technology development and sales company, has signed
a global licensing agreement with the University of Pittsburgh
to utilize Transcutaneous Near Field Communication (TNFC) technology in “smart”
medical devices for orthopaedic implants and recipient patients. In addition,
Ortho-tag and the University
of Pittsburgh’s Swanson
School of Engineering entered into an agreement for the on-going research for
future Ortho-tag technologies and products.

TNFC is a critical component of the Ortho-tag stable of
products which enables the transcutaneous transmission of information between
the patented Orthotag affixed to an orthopaedic implant and a proprietary
Ortho-tag Touch Probe/Reader. As part of an all-inclusive system, the Orthotag
enables orthopaedic surgeons to easily identify vital information about a
patient’s orthopaedic implant. Included in the ground-breaking technology is an
Ortho-tag Card which is designed for all previous implant patients as well as
future ones. The Ortho-tag Card gives patients the ability to have with them,
at all times, pertinent information related to their implant and implant
surgery.

According to Ortho-tag’s CEO Ken Laing, “The cutting-edge
technology of the Ortho-tag System is a result of the joint research among
innovative orthopaedic surgeons, engineers, and the University of Pittsburgh.
This technology will bring patient care to an all new level and is not only
designed for surgeons, but driven by surgeons.”

For more information please visit www.Ortho-tag.com.

Posted by Sean Fenske, Editor-in-Chief, MDT